Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 283

    Suven Life Sciences Pashamylaram facility successfully completes USFDA inspection

    Suven Life Sciences Pashamylaram facility successfully completes USFDA inspection

    Medical Dialogues Bureau8 May 2018 11:09 AM IST
    NEW DELHI: Drug firm Suven Life Sciences today said its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health...
    India signs up for USD 200-million loan from World Bank for nutrition mission

    India signs up for USD 200-million loan from World Bank for nutrition mission

    Medical Dialogues Bureau8 May 2018 9:50 AM IST
    New Delhi: India signed an agreement with the World Bank on Monday for a USD 200-million loan for the National Nutrition Mission (POSHAN Abhiyaan) to...
    Zydus Cadila gets USFDA nod for anesthesia drug

    Zydus Cadila gets USFDA nod for anesthesia drug

    Medical Dialogues Bureau7 May 2018 11:47 AM IST
    Drug firm Zydus Cadila today said it has received an approval from the US health regulator to market Succinylcholine Chloride injection, used as part...
    Marksans Pharma arm recalls unspecified number of Ibuprofen tablets from US

    Marksans Pharma arm recalls unspecified number of Ibuprofen tablets from US

    Medical Dialogues Bureau7 May 2018 11:46 AM IST
    New Delhi: Marksans Pharma's arm Time-Cap Laboratories Inc is withdrawing unspecified number of Ibuprofen tablets, manufactured in Goa, in multiple...
    Fortis shareholders approve acquisition of RHT Health Trust assets

    Fortis shareholders approve acquisition of RHT Health Trust assets

    Medical Dialogues Bureau7 May 2018 9:39 AM IST
    Fortis Healthcare today said its shareholders have approved a resolution to acquire assets of RHT Health Trust.In a regulatory filing, the company...
    FDA approves Novartis combo therapy for aggressive type of thyroid cancer

    FDA approves Novartis combo therapy for aggressive type of thyroid cancer

    Ruby Khatun Khatun6 May 2018 10:15 AM IST
    The U.S. Food and Drug Administration (FDA) approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of...
    Siemens net profit up 18 percent at Rs 219 crore in March quarter

    Siemens net profit up 18 percent at Rs 219 crore in March quarter

    Ruby Khatun Khatun6 May 2018 10:00 AM IST
    New Delhi: Siemens posted 18 percent jump in its standalone net profit to Rs 219.7 crore in the quarter ended March 31, mainly on account of higher...
    Currency headwinds sap Bayer in Q1

    Currency headwinds sap Bayer in Q1

    Ruby Khatun Khatun6 May 2018 9:45 AM IST
    German chemicals firm Bayer said exchange rate headwinds had undermined revenues and profits in the first quarter but kept its eyes on a planned...
    Moberg Pharma divests Balmex for 4.25 million dollars

    Moberg Pharma divests Balmex for 4.25 million dollars

    Ruby Khatun Khatun6 May 2018 9:30 AM IST
    Moberg Pharma AB has entered into an agreement with Randob Labs to divest the brand Balmex® for a total consideration of $4.25 million (34.6 million...
    Fortis appoints Arpwood Capital to advise on sale bids

    Fortis appoints Arpwood Capital to advise on sale bids

    Ruby Khatun Khatun5 May 2018 10:30 AM IST
    New Delhi: Fortis Healthcare said it has appointed Arpwood Capital Private Ltd to advise the board on various sale bids.The firm will act as financial...
    Zydus Cadila gets USFDA nod to market edema tablets

    Zydus Cadila gets USFDA nod to market edema tablets

    Ruby Khatun Khatun5 May 2018 10:15 AM IST
    New Delhi: Zydus Cadila said it has received final approval from the US health regulator to market Bumetanide tablets used for the treatment of edema...
    Here are 5 startup platforms for better health

    Here are 5 startup platforms for better health

    Ruby Khatun Khatun5 May 2018 10:00 AM IST
    New Delhi: The startup scenario in India has witnessed a tremendous change in the last few years. This has helped strengthen the country's position as...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Biocon, Mylan get European Commission approval to market biosimilar insulin glargine

    Biocon, Mylan get European Commission approval to market biosimilar insulin glargine

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    HUL expects to complete merger with GSK Consumer Healthcare in 2019

    HUL expects to complete merger with GSK Consumer Healthcare in 2019

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok